Preovulatory Treatment of Mice with Anti-VEGF Receptor 2 Antibody Inhibits Angiogenesis in Corpora Lutea

Author： Zimmermann R.C. Hartman T. Bohlen P. Sauer M.V. Kitajewski J.

ISSN： 0026-2862

Source： Microvascular Research, Vol.62, Iss.1, 2001-07, pp. : 15-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Local Anti-VEGF Antibody Treatment on Tumor Microvessel Permeability

By Lichtenbeld H.C. Ferarra N. Jain R.K. Munn L.L.

Microvascular Research, Vol. 57, Iss. 3, 1999-05 ,pp. : 357-362

Academic Press

Access to resources Recommend Favorite

Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice

By Zhou Z.

Angiogenesis, Vol. 3, Iss. 2, 1999-01 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro

By Wang Yaning

Angiogenesis, Vol. 7, Iss. 4, 2004-12 ,pp. : 335-345

Springer Publishing Company

Access to resources Recommend Favorite

Retrospective Study as First-Line Chemotherapy Combined Anti-VEGF Antibody with Fluoropyrimidine for Frail Patients with Unresectable or Metastatic Colorectal Cancer

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 59-64

Karger

Access to resources Recommend Favorite

The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma

By Drevs J.

Angiogenesis, Vol. 7, Iss. 4, 2004-12 ,pp. : 347-354

Springer Publishing Company

Access to resources Recommend Favorite